The potential involvement of the NF-κB pathway was investigated because the promoters for both IL-6 and IL-8 contain a binding site for NF-κB and this transcription factor is known to be involved in neurological disorders associated with increased inflammation [37-40]. Here, IL6 is linked to nervous system disorder.